Membership information

Our members give Emerge Australia the impetus, encouragement and drive to continue our work. By joining and supporting us, you will be helping to advance our cause to improve the lives of everyone with ME/CFS and their families. You'll also benefit by receiving our flagship quarterly journal Emerge delivered straight to your doormat or inbox as soon as it's published, and you'll be the first to know about member-only events and opportunities. Membership costs as little as $5.

Who is membership for?

We encourage anyone living with ME/CFS, their carers, family and friends, and any other supporters to become members. As our membership grows, our voice and ability to speak on your behalf grows louder.

How much does a membership cost?

Emerge Australia has two tiers of membership:

$50 (incl GST) annual membership
$5 (incl GST) annual membership (financial hardship)

Each tier gives the same benefits. Financial hardship is self-defined and does not require documentation.

What are the benefits of membership?

You will receive:

four issues of our quarterly journal, the Emerge magazine
a monthly newsletter
access to occasional member-only events

How do I become a member?

You can apply to become a member or renew your membership at any time online. If you would like assistance to complete this process, please contact the InfoLine on 03 9529 1344.

Your membership application is subject to the Membership Guidelines of the Association. In the event that your application does not comply with these guidelines, you will be advised accordingly and your membership fee will be refunded in full.

Once your membership application has been approved, it will be processed and you will receive a confirmation email, as well as a member pack in the mail. Membership processing times can be up to five working days.

Click here to sign up or renew your membership

Latest

Terms and Conditions of Purchase
Help us to educate people in power about ME/CFS

Help us to continue to improve our ability to educate people in power and people caring for those with ME/CFS
Research Digest 12/06/20

Welcome to the 49th edition of the Research Digest featuring a study investigating the role that Human herpesvirus 6A may play in ME/CFS pathogenesis and an Australian literature review on metabolomic dysregulation in ME/CFS.
Research Digest 29/05/20

Welcome to the 48th edition of the Research Digest featuring a study that investigates differences in immune gene SNP expression in ME/CFS and a systematic review on neurological impairments as measured by neuroimaging techniques.

Coronavirus and ME - Simplified facts

Many people with ME/CFS and other vulnerable communities in Australia are concerned about the impacts of the spreading coronavirus disease COVID-19. This is an easy-read resource with the latest information and advice.
Research Digest 06/03/20

Welcome to the 42nd edition, featuring a study into a potential clinically-suitable diagnostic biomarker for ME/CFS and a study that furthers our knowledge of the mitochondrial dysfunction exhibited by ME/CFS patients.
Diagnosis

How a diagnosis of myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) is made, the severity scale of ME/CFS, and the importance of early and accurate diagnosis
What is ME/CFS?

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, as well as the digestive, immune and cardiac systems, among others.
Accessibility
What is fibromyalgia?

Fibromyalgia is an associated condition of ME/CFS
Research Digest 03/04/20

Welcome to the 44th edition of the Research Digest. This edition features a recently published book that highlights the value of biomedical research in ME/CFS and a systematic review into the effect of treatment interventions on pain scores in paediatric ME/CFS patients.
Research Digest 20/03/20

Welcome to the 43rd edition of the Research Digest. This fortnight's edition features two studies that investigate new approaches to the way ME/CFS can be diagnosed using microRNA analysis and fMRI.
Research Digest 24/01/20

Welcome to the 39th edition, featuring a systematic review of ME/CFS randomized controlled trials and a study into the use of heart rate variability as a non-invasive biomarker for predicting fatigue severity in ME/CFS patients.
Research Digest 15/05/20

Welcome to the 47th edition of the Research Digest. This fortnight's edition digests a whole brain MRS study looking at metabolite abnormalities in the brains of ME/CFS patients and a French study investigating muscle excitability in exercising and resting muscles of patients diagnosed with ME/CFS.